Pharos Capital

·

Pharos IV

·

Renal Care 360º

Nephrology and Chronic Care Management.

Teachers trained in digital tools

Company Profile

FUND

Pharos IV

Status

Current

Year of Investment

2022

location

Nashville, TN

sector

Nephrology / Chronic Care Management

strategic focus

Early detection and care coordination across PCPs, nephrologists, and physician groups

Renal Care 360º is a comprehensive nephrology practice and chronic care management company partnering with health systems, physician groups, and local communities to provide enhanced community healthcare management services. Its Connected Care Program partners with PCPs, nephrologists, and other physician groups to augment existing services by providing patients with a customized care coordination and education program tailored to each patient's health needs. In addition to contracted chronic care management services, Renal Care 360º intends to acquire nephrology practices that share its passion to transform kidney care through early detection and deep patient engagement with comprehensive care management.

Three Ways to Work with Pharos

Whether you're allocating capital or building a healthcare company, we start with the same question: does this serve the communities that need it most?

Investors

Pharos partners with foundations, family offices, and institutional investors who want competitive returns from healthcare companies serving underserved communities.

Founders & Operators

We invest $25 to $50 million in established, U.S.-based healthcare companies positioned to reduce disparities in underserved communities and scale toward a potentially successful exit. If your company fits that profile, we want to hear from you.

Healthcare Partners

If you are a payor, hospital, health system, or governmental agency that services rural, tribal, or other complex underserved populations, we would welcome the opportunity to share existing solutions we have identified or to use our network to source new solutions for the problems these communities face.